Yanagisawa, Takafumi http://orcid.org/0000-0002-7410-0712
Kawada, Tatsushi
Quhal, Fahad
Bekku, Kensuke
Laukhtina, Ekaterina
Rajwa, Pawel
von Deimling, Markus
Majdoub, Muhammad
Chlosta, Marcin
Pradere, Benjamin
Mori, Keiichiro
Kimura, Takahiro
Schmidinger, Manuela
Karakiewicz, Pierre I.
Shariat, Shahrokh F.
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 14 December 2022
Accepted: 8 April 2023
First Online: 20 May 2023
Declarations
:
: Takahiro Kimura is a paid consultant/advisor of Astellas, Bayer, Janssen and Sanofi. Shahrokh F. Shariat received follows: Honoraria: Astellas, AstraZeneca, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Roche, Takeda Consulting or Advisory Role: Astellas, AstraZeneca, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Pierre Fabre, Roche, Takeda Speakers Bureau: Astellas, Astra Zeneca, Bayer, BMS, Ferring, Ipsen, Janssen, MSD, Olympus, Pfizer, Richard Wolf, Roche, Takeda, The other authors declare no conflicts of interest associated with this manuscript.